Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 33.53B | 33.71B | 30.47B | 27.45B | 27.39B | 25.41B |
Gross Profit | 4.80B | 5.17B | 5.01B | 2.55B | 1.39B | 381.00M |
EBITDA | 2.79B | 4.12B | 3.62B | 3.89B | 1.78B | 398.00M |
Net Income | 274.00M | 1.38B | 656.00M | 943.00M | -1.05B | -3.29B |
Balance Sheet | ||||||
Total Assets | 95.10B | 104.08B | 98.40B | 94.11B | 92.50B | 92.12B |
Cash, Cash Equivalents and Short-Term Investments | 3.50B | 4.05B | 3.97B | 4.45B | 5.29B | 5.29B |
Total Debt | 27.36B | 26.78B | 25.72B | 27.69B | 26.69B | 21.90B |
Total Liabilities | 53.74B | 61.32B | 56.79B | 54.89B | 53.81B | 52.74B |
Stockholders Equity | 40.35B | 41.72B | 40.65B | 38.36B | 37.81B | 38.39B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -2.27B | 1.12B | -4.58B | -5.01B | -2.66B |
Operating Cash Flow | 0.00 | 5.08B | 5.53B | 449.00M | -1.12B | 2.89B |
Investing Cash Flow | 0.00 | -5.57B | -3.65B | -2.15B | -3.56B | -2.94B |
Financing Cash Flow | 0.00 | 604.00M | -2.36B | 894.00M | 4.66B | 1.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥292.88B | 12.73 | 1.55% | 7.02% | -11.48% | ||
70 Outperform | ¥13.52B | 7.55 | 0.29% | 1.27% | -6.53% | ||
70 Neutral | ¥19.65B | 13.13 | 1.25% | 6.14% | 191.46% | ||
68 Neutral | ¥46.53B | 12.37 | 1.68% | 2.43% | 34.21% | ||
67 Neutral | ¥19.72B | 16.70 | 0.81% | -0.12% | 10.36% | ||
64 Neutral | $10.95B | 16.37 | 8.81% | 1.96% | 2.68% | -15.33% | |
60 Neutral | ¥44.55B | 13.13 | 2.47% | 1.10% | -29.92% |